Article
Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer.
PloS one - 1 Jan 2014
Sanoff Hanna K, Renfro Lindsay A, Poonnen Pradeep, Ambadwar Pratibha, Sargent Daniel J, Goldberg Richard M, McLeod Howard
Abstract excerpt
BACKGROUND: Colorectal cancer (CRC) risk is partly conferred by common, low-penetrance single nucleotide polymorphisms (SNPs). We hypothesized that these SNPs are associated with outcomes in metastatic CRC. METHODS: Six candidate SNPs from 8q24, 10p14, 15q13, 18q21 were investigated for their association with response rate (RR), time to progression (TTP) and overall survival (OS) among 524 patients treated on a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
